Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds
10.1186/1758-2946-1-10
Crossref journal-article
Springer Science and Business Media LLC
Journal of Cheminformatics (297)
Bibliography

Southan, C., Várkonyi, P., & Muresan, S. (2009). Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds. Journal of Cheminformatics, 1(1).

Authors 3
  1. Christopher Southan (first)
  2. Péter Várkonyi (additional)
  3. Sorel Muresan (additional)
References 44 Referenced 55
  1. Southan C, Varkonyi P, Muresan S: Complementarity Between Public and Commercial Databases: New Opportunities in Medicinal Chemistry Informatics. Current Topics in Medicinal Chemistry. 2007, 7: 1502-1508. (10.2174/156802607782194761) / Current Topics in Medicinal Chemistry by C Southan (2007)
  2. Williams AJ: A perspective of publicly accessible/open-access chemistry databases. Drug Discovery Today. 2008, 13: 495-501. (10.1016/j.drudis.2008.03.017) / Drug Discovery Today by AJ Williams (2008)
  3. Murray-Rust P: Chemistry for everyone. Nature. 2008, 451: 648-651. (10.1038/451648a) / Nature by P Murray-Rust (2008)
  4. ChemSpider. [http://www.chemspider.com]
  5. PubChem. [http://pubchem.ncbi.nlm.nih.gov]
  6. eMolecules. [http://www.emolecules.com]
  7. Irwin JJ, Shoichet BK: ZINC – A Free Database of Commercially Available Compounds for Virtual Screening. J Chem Inf Model. 2005, 45 (1): 177-182. (10.1021/ci049714+) / J Chem Inf Model by JJ Irwin (2005)
  8. Ertl P, Jelfs S: Designing Drugs on the Internet? Free Web Tools and Services Supporting Medicinal Chemistry. Current Topics in Medicinal Chemistry. 2007, 7 (11): 1491-1501. (10.2174/156802607782194707) / Current Topics in Medicinal Chemistry by P Ertl (2007)
  9. Williams AJ: Public chemical compound databases. Current Opinion in Drug Discovery & Development. 2008, 11: 393-404. / Current Opinion in Drug Discovery & Development by AJ Williams (2008)
  10. Jonsdottir SO, Jorgensen FS, Brunak S: Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates. Bioinformatics. 2005, 21: 2145-2160. (10.1093/bioinformatics/bti314) / Bioinformatics by SO Jonsdottir (2005)
  11. Zhou Y, Zhou B, Chen K, Yan SF, King FJ, Jiang S, Winzeler EA: Large-Scale Annotation of Small-Molecule Libraries Using Public Databases. J Chem Inf Model. 2007, 47 (4): 1386-1394. (10.1021/ci700092v) / J Chem Inf Model. by Y Zhou (2007)
  12. DiscoveryGate. [https://www.discoverygate.com]
  13. Thompson Pharma. [http://www.thomsonscientific.com]
  14. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research. 2008, 36: D901-906. (10.1093/nar/gkm958) / Nucleic Acids Research by DS Wishart (2008)
  15. Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK: BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research. 2007, 35: D198-201. (10.1093/nar/gkl999) / Nucleic Acids Research by T Liu (2007)
  16. Degtyarenko K, de Matos P, Ennis M, Hastings J, Zbinden M, McNaught A, Alcantara R, Darsow M, Guedj M, Ashburner M: ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Research. 2008, 36: D344-350. (10.1093/nar/gkm791) / Nucleic Acids Research by K Degtyarenko (2008)
  17. Fleischmann A, Darsow M, Degtyarenko K, Fleischmann W, Boyce S, Axelsen KB, Bairoch A, Schomburg D, Tipton KF, Apweiler R: IntEnz, the integrated relational enzyme database. Nucleic Acids Research. 2004, 32: D434-437. (10.1093/nar/gkh119) / Nucleic Acids Research by A Fleischmann (2004)
  18. Kanehisa M, Arak M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y: KEGG for linking genomes to life and the environment. Nucleic Acids Research. 2008, 36: D480-484. (10.1093/nar/gkm882) / Nucleic Acids Research by M Kanehisa (2008)
  19. Olah M, Rad R, Ostopovici L, Bora A, Hadanga N, Hadaruga D, Moldovan R, Fulias A, Mracec M, Oprea TI: WOMBAT and WOMBAT-PK: Bioactivity Databases for Lead and Drug Discovery. Chemical Biology: From Small Molecules to Systems Biology and Drug Design. Edited by: Schreiber SL, Kapoor P, Wess G. 2007, Wiley-VCH: New York, 760-786. (10.1002/9783527619375.ch13b) / Chemical Biology: From Small Molecules to Systems Biology and Drug Design by M Olah (2007)
  20. GVKBIO database. [http://www.gvkbio.com]
  21. Varkonyi P, Hoppe C, Muresan S: IBEX – access and exploit SAR data from patents and journals. Proceedings of ChemAxon UGM: 7–8 June 2008, Budapest. 2008, [http://www.chemaxon.com/forum/viewpost16936.html#16936] / Proceedings of ChemAxon UGM: 7–8 June 2008, Budapest by P Varkonyi (2008)
  22. MDL Drug Data Report produced by Symyx and Prous Science. [http://www.symyx.com/products/databases/bioactivity/mddr/index.jsp]
  23. Dictionary of Natural Products. 2005, Chapman & Hall/CRC Press LLC: London, [http://www.crcpress.com]
  24. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001, 46 (1-3): 3-26. (10.1016/S0169-409X(00)00129-0) / Adv Drug Deliv Rev by CA Lipinski (2001)
  25. Hunt CE, Turner AJ: Cell biology, regulation and inhibition of β-secretase (BACE-1). FEBS Journal. 2009, 276: 1845-1859. (10.1111/j.1742-4658.2009.06929.x) / FEBS Journal by CE Hunt (2009)
  26. Engels MFM, Gibbs AC, Jaeger EP, Verbinnen D, Lobanov VS, Agrafiotis DK: A Cluster-Based Strategy for Assessing the Overlap between Large Chemical Libraries and Its Application to a Recent Acquisition. J Chem Inf Model. 2006, 46 (6): 2651-2660. (10.1021/ci600219n) / J Chem Inf Model by MFM Engels (2006)
  27. Kenny PW, Sadowski J: Structure Modification in Chemical Databases. Chemoinformatics in Drug Discovery. Edited by: Oprea IT. 2005, Wiley-VCH Verlag GmbH & Co. KGaA, 23: 271-285. (10.1002/3527603743.ch11) / Chemoinformatics in Drug Discovery by PW Kenny (2005)
  28. Ihlenfeldt WD, Gasteiger J: Hash codes for the identification and classification of molecular structure elements. Journal of Computational Chemistry. 1994, 15: 793-813. (10.1002/jcc.540150802) / Journal of Computational Chemistry by WD Ihlenfeldt (1994)
  29. OpenEye Scientific Software, Inc., Santa Fe, NM. [http://www.eyesopen.com]
  30. Hughes B: 2007 FDA drug approvals: a year of flux. Nature Reviews Drug Discovery. 2008, 7: 107-109. (10.1038/nrd2514) / Nature Reviews Drug Discovery by B Hughes (2008)
  31. UniProt Knowledgebase. [http://www.uniprot.org/docs/dbxref]
  32. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there?. Nature Reviews Drug Discovery. 2006, 5: 993-996. (10.1038/nrd2199) / Nature Reviews Drug Discovery by JP Overington (2006)
  33. Russ AP, Lampel S: The druggable genome: an update. Drug Discovery Today. 2005, 10: 1607-1610. (10.1016/S1359-6446(05)03666-4) / Drug Discovery Today by AP Russ (2005)
  34. Paolini GV, Shapland RHB, van Hoorn WP, Mason JS, Hopkins AL: Global mapping of pharmacological space. Nature Biotechnology. 2006, 24: 805-815. (10.1038/nbt1228) / Nature Biotechnology by GV Paolini (2006)
  35. Hopkins AL, Groom CR: The druggable genome. Nature Reviews Drug Discovery. 2002, 1: 727-730. (10.1038/nrd892) / Nature Reviews Drug Discovery by AL Hopkins (2002)
  36. Nidhi , Glick M, Davies JW, Jenkins JL: Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases. J Chem Inf Model. 2006, 46 (3): 1124-1133. (10.1021/ci060003g) / J Chem Inf Model. by Nidhi (2006)
  37. SureChem. [http://www.surechem.org]
  38. MLSMR project. [http://mlsmr.glpg.com/MLSMR_HomePage/identify.html]
  39. Ma'ayan A, Jenkins SL, Goldfarb J, Iyengar R: Network analysis of FDA approved drugs and their targets. Mt Sinai J Med. 2007, 74 (1): 27-32. (10.1002/msj.20002) / Mt Sinai J Med by A Ma'ayan (2007)
  40. List of drugs. [http://en.wikipedia.org/wiki/List_of_drugs]
  41. ChEMBL. [http://www.ebi.ac.uk/chembl]
  42. Houlton S: Wellcome boost for open-access chemistry. Nature Reviews Drug Discovery. 2008, 7: 789-790. (10.1038/nrd2723) / Nature Reviews Drug Discovery by S Houlton (2008)
  43. Freepatentsonline. [http://www.freepatentsonline.com]
  44. MicroPatent. [http://www.micropat.com]
Dates
Type When
Created 16 years, 1 month ago (July 7, 2009, 2:14 a.m.)
Deposited 3 years, 11 months ago (Sept. 1, 2021, 3:59 a.m.)
Indexed 1 year, 1 month ago (July 4, 2024, 10:52 p.m.)
Issued 16 years, 1 month ago (July 6, 2009)
Published 16 years, 1 month ago (July 6, 2009)
Published Online 16 years, 1 month ago (July 6, 2009)
Published Print 15 years, 8 months ago (Dec. 1, 2009)
Funders 0

None

@article{Southan_2009, title={Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds}, volume={1}, ISSN={1758-2946}, url={http://dx.doi.org/10.1186/1758-2946-1-10}, DOI={10.1186/1758-2946-1-10}, number={1}, journal={Journal of Cheminformatics}, publisher={Springer Science and Business Media LLC}, author={Southan, Christopher and Várkonyi, Péter and Muresan, Sorel}, year={2009}, month=jul }